Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Rare and Resistant Cancers

  • Young patient inspires gift from stranger

    Young patient inspires gift from stranger

    Bob Ripley reads every issue of Impact cover to cover. While reading the Late Fall 2021 edition, he was very moved by one story in particular.

    Continue Reading

  • Joe Connolly

    Joe Connolly

    Joe Connolly gave $100,000 to fund critical small cell lung cancer research at Dana-Farber. Established in honor of Connolly’s late wife, the Deborah A. Connolly Small Cell Lung Cancer Research Fund is supporting Jacob Sands, MD, who in collaboration with Matthew Oser, MD, PhD, is exploring new methods to predict drug resistance and detect cancer…

    Continue Reading

  • Campbells advance research into rare ovarian cancer

    Campbells advance research into rare ovarian cancer

    Emily Campbell was just 32 when she began seeing doctors in her hometown of Miami for vague symptoms—abdominal discomfort and bloating, low appetite, fatigue—that were dismissed by her local medical team until she insisted on an ultrasound scan.

    Continue Reading

  • American Gastroenterological Association

    American Gastroenterological Association

    The American Gastroenterological Association awarded $300,000 to support a Dana-Farber study into pancreatic ductal adenocarcinoma (PDAC), an aggressive disease that currently has limited and short-lasting treatment options. This funding will enable Jeffrey Patterson-Fortin, MD, PhD, to gain insights into how PDAC responds to immune-based therapies that could provide longer term benefit for patients.

    Continue Reading

  • The Cancer Couch Foundation

    The Cancer Couch Foundation

    The Cancer Couch Foundation has granted $225,000 to support the work of Daniel Abravanel, MD, PhD. The funds will drive Abravanel’s research on how drug resistance arises in metastatic breast cancer and foster the development of innovative strategies for improving treatments for patients with this challenging form of the disease.

    Continue Reading

  • Brenda McAdam

    Brenda McAdam

    After being diagnosed with cholangiocarcinoma, a rare bile duct cancer, in August 2022, Brenda McAdam established the Brenda McAdam Fund for Bile Duct Cancer Research at Dana-Farber under the direction of James Cleary, MD, PhD. With her $100,000 gift, she hopes Cleary can help patients like her defy this rare cancer.

    Continue Reading

  • Oligo Nation

    Oligo Nation

    Dana-Farber recently received a $100,000 grant from Oligo Nation to advance vital research on oligodendroglioma, a rare type of brain tumor. This grant propels efforts to develop treatment strategies to target dependencies conferred by IDH oncogenes in this disease.

    Continue Reading

  • Doron Broman

    Doron Broman

    Doron Broman, a Miami-based real estate developer and stage IV pancreatic cancer patient, has given $150,000 to support research in pancreatic cancer under the direction of Kimmie Ng, MD, MPH. Broman came to Dana-Farber in 2015 with only months to live, but under the treatment of Ng, has defied the odds and is celebrating seven…

    Continue Reading

  • Matthew Miller

    Matthew Miller

    Matthew Miller gave $100,000 to advance groundbreaking investigations in melanoma led by Rizwan Haq, MD, PhD. Miller’s support will help Haq uncover the genomic intricacies of drug resistance and explore new ways to enhance personalized medicine for patients.

    Continue Reading

  • Radical collaborations target intractable cancers

    Radical collaborations target intractable cancers

    BTC has awarded $22.9 million in grants to Dana-Farber researchers working across multiple institutions to unlock the secrets of four difficult-to-treat cancers and intercept or develop cutting-edge treatments for them.

    Continue Reading